239 related articles for article (PubMed ID: 35835915)
1. YAP induces an oncogenic transcriptional program through TET1-mediated epigenetic remodeling in liver growth and tumorigenesis.
Wu BK; Mei SC; Chen EH; Zheng Y; Pan D
Nat Genet; 2022 Aug; 54(8):1202-1213. PubMed ID: 35835915
[TBL] [Abstract][Full Text] [Related]
2. TET1 upregulation drives cancer cell growth through aberrant enhancer hydroxymethylation of HMGA2 in hepatocellular carcinoma.
Shirai K; Nagae G; Seki M; Kudo Y; Kamio A; Hayashi A; Okabe A; Ota S; Tsutsumi S; Fujita T; Yamamoto S; Nakaki R; Kanki Y; Osawa T; Midorikawa Y; Tateishi K; Ichinose M; Aburatani H
Cancer Sci; 2021 Jul; 112(7):2855-2869. PubMed ID: 33970549
[TBL] [Abstract][Full Text] [Related]
3. FOXA1 potentiates lineage-specific enhancer activation through modulating TET1 expression and function.
Yang YA; Zhao JC; Fong KW; Kim J; Li S; Song C; Song B; Zheng B; He C; Yu J
Nucleic Acids Res; 2016 Sep; 44(17):8153-64. PubMed ID: 27257062
[TBL] [Abstract][Full Text] [Related]
4. The PDZ-binding motif of Yes-associated protein is required for its co-activation of TEAD-mediated CTGF transcription and oncogenic cell transforming activity.
Shimomura T; Miyamura N; Hata S; Miura R; Hirayama J; Nishina H
Biochem Biophys Res Commun; 2014 Jan; 443(3):917-23. PubMed ID: 24380865
[TBL] [Abstract][Full Text] [Related]
5. Mono-ADP-ribosylation of H3R117 traps 5mC hydroxylase TET1 to impair demethylation of tumor suppressor gene TFPI2.
Li M; Tang Y; Li Q; Xiao M; Yang Y; Wang Y
Oncogene; 2019 May; 38(18):3488-3503. PubMed ID: 30651599
[TBL] [Abstract][Full Text] [Related]
6. Poly(ADP-ribosyl)ation is involved in the epigenetic control of TET1 gene transcription.
Ciccarone F; Valentini E; Bacalini MG; Zampieri M; Calabrese R; Guastafierro T; Mariano G; Reale A; Franceschi C; Caiafa P
Oncotarget; 2014 Nov; 5(21):10356-67. PubMed ID: 24939750
[TBL] [Abstract][Full Text] [Related]
7. Loss of TET1 facilitates DLD1 colon cancer cell migration via H3K27me3-mediated down-regulation of E-cadherin.
Zhou Z; Zhang HS; Liu Y; Zhang ZG; Du GY; Li H; Yu XY; Huang YH
J Cell Physiol; 2018 Feb; 233(2):1359-1369. PubMed ID: 28513825
[TBL] [Abstract][Full Text] [Related]
8. Oncogenic EGFR Represses the TET1 DNA Demethylase to Induce Silencing of Tumor Suppressors in Cancer Cells.
Forloni M; Gupta R; Nagarajan A; Sun LS; Dong Y; Pirazzoli V; Toki M; Wurtz A; Melnick MA; Kobayashi S; Homer RJ; Rimm DL; Gettinger SJ; Politi K; Dogra SK; Wajapeyee N
Cell Rep; 2016 Jul; 16(2):457-471. PubMed ID: 27346347
[TBL] [Abstract][Full Text] [Related]
9. TET1 regulates hypoxia-induced epithelial-mesenchymal transition by acting as a co-activator.
Tsai YP; Chen HF; Chen SY; Cheng WC; Wang HW; Shen ZJ; Song C; Teng SC; He C; Wu KJ
Genome Biol; 2014 Dec; 15(12):513. PubMed ID: 25517638
[TBL] [Abstract][Full Text] [Related]
10. TET1 dioxygenase is required for FOXA2-associated chromatin remodeling in pancreatic beta-cell differentiation.
Li J; Wu X; Ke J; Lee M; Lan Q; Li J; Yu J; Huang Y; Sun DQ; Xie R
Nat Commun; 2022 Jul; 13(1):3907. PubMed ID: 35798741
[TBL] [Abstract][Full Text] [Related]
11. ERK/c-Jun Recruits Tet1 to Induce Zta Expression and Epstein-Barr Virus Reactivation through DNA Demethylation.
Zhang W; Han D; Wan P; Pan P; Cao Y; Liu Y; Wu K; Wu J
Sci Rep; 2016 Oct; 6():34543. PubMed ID: 27708396
[TBL] [Abstract][Full Text] [Related]
12. Role of TET1-mediated epigenetic modulation in Alzheimer's disease.
Armstrong MJ; Jin Y; Vattathil SM; Huang Y; Schroeder JP; Bennet DA; Qin ZS; Wingo TS; Jin P
Neurobiol Dis; 2023 Sep; 185():106257. PubMed ID: 37562656
[TBL] [Abstract][Full Text] [Related]
13. Multiple Functions of Ten-eleven Translocation 1 during Tumorigenesis.
Tian YP; Zhu YM; Sun XH; Lai MD
Chin Med J (Engl); 2016 Jul; 129(14):1744-51. PubMed ID: 27411465
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic inactivation of the CpG demethylase TET1 as a DNA methylation feedback loop in human cancers.
Li L; Li C; Mao H; Du Z; Chan WY; Murray P; Luo B; Chan AT; Mok TS; Chan FK; Ambinder RF; Tao Q
Sci Rep; 2016 May; 6():26591. PubMed ID: 27225590
[TBL] [Abstract][Full Text] [Related]
15. Chronic ethanol-mediated hepatocyte apoptosis links to decreased TET1 and 5-hydroxymethylcytosine formation.
Ji C; Nagaoka K; Zou J; Casulli S; Lu S; Cao KY; Zhang H; Iwagami Y; Carlson RI; Brooks K; Lawrence J; Mueller W; Wands JR; Huang CK
FASEB J; 2019 Feb; 33(2):1824-1835. PubMed ID: 30188753
[TBL] [Abstract][Full Text] [Related]
16. Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP.
Liu-Chittenden Y; Huang B; Shim JS; Chen Q; Lee SJ; Anders RA; Liu JO; Pan D
Genes Dev; 2012 Jun; 26(12):1300-5. PubMed ID: 22677547
[TBL] [Abstract][Full Text] [Related]
17. GADD45a physically and functionally interacts with TET1.
Kienhöfer S; Musheev MU; Stapf U; Helm M; Schomacher L; Niehrs C; Schäfer A
Differentiation; 2015; 90(1-3):59-68. PubMed ID: 26546041
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic silencing of TET1 mediated hydroxymethylation of base excision repair pathway during lung carcinogenesis.
Chen HQ; Chen DJ; Li Y; Yuan WB; Fan J; Zhang Z; Han F; Jiang X; Chen JP; Wang DD; Cao J; Liu JY; Liu WB
Environ Pollut; 2021 Jan; 268(Pt B):115860. PubMed ID: 33120142
[TBL] [Abstract][Full Text] [Related]
19. TET1 is a negative transcriptional regulator of IL-1β in the THP-1 cell line.
Neves-Costa A; Moita LF
Mol Immunol; 2013 Jul; 54(3-4):264-70. PubMed ID: 23328087
[TBL] [Abstract][Full Text] [Related]
20. Identification of MLL-fusion/MYC⊣miR-26⊣TET1 signaling circuit in MLL-rearranged leukemia.
Huang H; Jiang X; Wang J; Li Y; Song CX; Chen P; Li S; Gurbuxani S; Arnovitz S; Wang Y; Weng H; Neilly MB; He C; Li Z; Chen J
Cancer Lett; 2016 Mar; 372(2):157-65. PubMed ID: 26791235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]